Melanoma

If you have been NEWLY DIAGNOSED  START HERE 

Cancer Journey


VIDEOS

GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow...

GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow...

GRACE is excited to bring you a new series on current updates in Melanoma Treatment. Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow...

GRACE is excited to bring you a new series on current updates in Melanoma Treatment Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow...

Telemedicina y telesalud: cómo COVID 19 ha transformado la atención del cáncer En este video de discusión, el Dr. Narjust Duma habla con los Dres...

ARTICLES

El sexo es esa palabra que puede significar y sentirse de forma tan diferente dependiendo del contexto de nuestras vidas. Como jóvenes adolescentes...

In this giving season, we thank you for your generosity. Your donation helps thousands of people living with cancer become educated about their...

Have you received a diagnosis of ovarian cancer? GRACE is excited to have again partnered with Clinical Care Options to develop an Interactive...

Covid-19 Financial Impacts and Resources for the Cancer Patient As many of you know, the costs of treating a new disease or virus are often...

The staff at GRACE is concerned like everyone regarding the Novel Coronavirus (COVID-19) and are committed to providing information that benefits and...

COMMUNITY FORUM

RECENT POSTS

2020 MELANOMA - POSTOW - Understanding Immunotherapy Resistance Mechanisms in Melanoma

Video
GRACE is excited to bring you a new series on current updates in Melanoma Treatment.

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.

In this video, Dr. Postow discusses understanding immunotherapy resistance mechanisms in melanoma.

 

A huge thank you to Merck for sponsoring this program.

2020 MELANOMA - POSTOW - Future Prospects for Immunotherapy Agents in Advanced Melanoma

Video
GRACE is excited to bring you a new series on current updates in Melanoma Treatment.

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.

In this video, Dr. Postow discusses future prospects for immunotherapy agents in advanced melanoma.

 

A huge thank you to Merck for sponsoring this program.

2020 MELANOMA - MCKEAN - Is there a Role for Molecular Testing in Early Melanoma Management

Video
GRACE is excited to bring you a new series on current updates in Melanoma Treatment.

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.

In this video, Dr. McKean discusses if there is a role for molecular testing in early melanoma management.

 

2020 MELANOMA - MCKEAN - Current Status of Sentinel Lymph Node Mapping & Completion Lymphadenectomy

Video
GRACE is excited to bring you a new series on current updates in Melanoma Treatment.

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.

In this video, Dr. McKean discusses the current status of sentinel lymph node mapping and completion lymphadenectomy.

 

Metastatic Melanoma-Combination immunotherapy vs. monotherapy

In this video, Dr. McKean discusses combination immunotherapy vs.
I joined GRACE as a caregiver for my husband who had a Pancoast tumor, NSCLC stage III in 2009. He had curative chemo/rads then it was believed he had a recurrence in the spine/oligometastasis that was radiated. He's 10 years out from treatment.

Melanoma Updates - AGARWALA - Adjuvant Therapy of Melanoma

Video
GRACE is excited to bring you a new series on current updates in Melanoma Treatment.

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chiefof Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.

In this video, Dr. Agarwala discusses adjuvant therapy for melanoma.

 

A huge thank you to our sponsor, Merck!

2020 MELANOMA - MCKEAN - Combination Immunotherapy vs Monotherapy for Metastatic Melanoma

Video
GRACE is excited to bring you a new series on current updates in Melanoma Treatment

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma service at Memorial Sloan Kettering and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.   

 
In this video, Dr. McKean discusses combination immunotherapy vs. monotherapy for Metastatic Melanoma.

 

A huge thank you to our sponsor, Merck!

Tulane University online survey - looking for individuals with a cancer diagnosis

The research team at Tulane University is conducting an online survey of individuals with cancer. 

GRACE has been asked to share information about an anonymous one-time online research study about personality and cancer care. They are looking for adults with a history of cancer. A total number of 2,500 individuals will participate in the study, recruited from various social media platforms and websites dedicated to cancer research and patient support.

 

Operations Director for GRACE. Have worked with cancerGRACE.org since July 2009.  Became involved as a caregiver to my best friend, and quickly came to see that GRACE is filling a need in the area of cancer education. 
Subscribe to Melanoma